Companies included in HRTS
This is HRTS's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–44 of 44.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| LLY | Eli Lilly & Co | 5,263 | NS | 10.008632% |
| RHHBY | Roche Holding AG | 50,740 | NS | 5.462129% |
| JNJ | Johnson & Johnson | 10,810 | NS | 4.854667% |
| AZN | AstraZeneca PLC | 12,706 | NS | 4.810875% |
| MRK | Merck & Co Inc | 18,918 | NS | 4.234438% |
| TMO | Thermo Fisher Scientific Inc | 4,137 | NS | 3.897128% |
| UNH | UnitedHealth Group Inc | 7,253 | NS | 3.845166% |
| GILD | Gilead Sciences Inc | 13,435 | NS | 3.617495% |
| NOVN | Novartis AG | 11,781 | NS | 3.614771% |
| ABT | Abbott Laboratories | 16,017 | NS | 3.368816% |
| VRTX | Vertex Pharmaceuticals Inc | 3,568 | NS | 3.204516% |
| ABBV | AbbVie Inc | 7,045 | NS | 2.955619% |
| DHR | Danaher Corp | 7,657 | NS | 2.915609% |
| BSX | Boston Scientific Corp | 17,749 | NS | 2.465741% |
| MDT | Medtronic PLC | 13,377 | NS | 2.361594% |
| BBIO | Bridgebio Pharma Inc | 18,567 | NS | 2.231323% |
| RVMD | Revolution Medicines Inc | 11,995 | NS | 2.212154% |
| BMY | Bristol-Myers Squibb Co | 19,189 | NS | 2.163505% |
| MCK | McKesson Corp | 1,210 | NS | 2.159708% |
| NOVOB | Novo Nordisk A/S | 31,589 | NS | 2.148304% |
| AMGN | Amgen Inc | 2,984 | NS | 2.09382% |
| 4519 | Chugai Pharmaceutical Co Ltd | 16,971 | NS | 2.053892% |
| REGN | Regeneron Pharmaceuticals Inc | 1,426 | NS | 2.014989% |
| EW | Edwards Lifesciences Corp | 11,887 | NS | 1.858093% |
| TEVA | Teva Pharmaceutical Industries | 26,392 | NS | 1.615433% |
| CYTK | Cytokinetics Inc | 13,108 | NS | 1.474335% |
| ISRG | Intuitive Surgical Inc | 1,610 | NS | 1.465425% |
| MASI | Masimo Corp | 4,286 | NS | 1.358588% |
| DXCM | Dexcom Inc | 9,698 | NS | 1.287317% |
| MDGL | Madrigal Pharmaceuticals Inc | 1,551 | NS | 1.211226% |
| INSM | Insmed Inc | 4,417 | NS | 1.192351% |
| ALNY | Alnylam Pharmaceuticals Inc | 1,972 | NS | 1.186797% |
| PODD | Insulet Corp | 2,336 | NS | 1.04139% |
| ARWR | Arrowhead Pharmaceuticals Inc | 8,970 | NS | 1.025935% |
| VKTX | Viking Therapeutics Inc | 13,867 | NS | 0.848287% |
| IONS | Ionis Pharmaceuticals Inc | 5,673 | NS | 0.832206% |
| SRRK | Scholar Rock Holding Corp | 9,773 | NS | 0.782109% |
| ASND | Ascendis Pharma A/S | 1,777 | NS | 0.750074% |
| CRNX | Crinetics Pharmaceuticals Inc | 8,655 | NS | 0.643041% |
| FXFXX | First American Treasury Obliga | 325,512.87 | NS | 0.588434% |
| NBIX | Neurocrine Biosciences Inc | 2,387 | NS | 0.570661% |
| ZLDPF | Zealand Pharma A/S | 5,363 | NS | 0.557745% |
| GUBRA | Gubra A/S | 4,545 | NS | 0.508014% |
| NTLA | Intellia Therapeutics Inc | 14,076 | NS | 0.350637% |
SEC N-PORT snapshot as of .